Actualités MedTech Acquisition Corporation - MTAC | Actions NASDAQ

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders

MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that it convened and then adjourned, without...

Statement of Changes in Beneficial Ownership (4)

FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...

Small Company Offering and Sale of Securities Without Registration (d)

UNITED STATES SECURITIESAND EXCHANGE COMMISSIONWashington, D.C.FORM DOMB APPROVALOMB Number: 3235-0076Estimated Average burden hours per...

Amended Statement of Beneficial Ownership (sc 13d/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange...

Current Report Filing (8-k)

0001826667 false --12-31 0001826667 2023-06-12 2023-06-12 0001826667...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Current Report Filing (8-k)

0001826667 false 0001826667 2023-06-12 2023-06-12 0001826667...

TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting

New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment and decreased circulating tumor...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

MedTech Acquisition Corporation (MTAC)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

MTAC Actualités

MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders

Statement of Changes in Beneficial Ownership (4)

Small Company Offering and Sale of Securities Without Registration (d)

Amended Statement of Beneficial Ownership (sc 13d/a)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Proxy Statement (definitive) (def 14a)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

MedTech Acquisition Corporation (MTAC) Actualités

MedTech Acquisition Corporation (MTAC)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

MTAC Actualités

MedTech Acquisition Corporation Adjourns Special Meeting of Stockholders

Statement of Changes in Beneficial Ownership (4)

Small Company Offering and Sale of Securities Without Registration (d)

Amended Statement of Beneficial Ownership (sc 13d/a)

Current Report Filing (8-k)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Proxy Statement (definitive) (def 14a)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités